Whare Tukutuku invites you to join the first of a three part webinar series about the reduction of alcohol and other drugs and associated harms within Māori communities.
Māori and Pacific people suffer much higher rates of mental illness and addiction than other New Zealanders - 1 in 3 for Māori and 1 in 4 for Pacific people, compared to 1 in 5 for the rest of the population. The Waitangi Tribunal has accused the New Zealand Health system of failing Māori, calling the inequities within the system a "crisis".
‘He Ara Waiora’ a 3-part Webinar series looks into why the Health System is failing Māori, and how other models of Health Care and cultural aptitude can help improve outcomes for tangata Māori in our Health Care system.
In webinar one, guests Tuari Potiki and Dr Vicki McFarlane will talk about equity and the Treaty of Waitangi.
Tuari Potiki is the Director Māori of the University of Otago’s Office of Māori Development, and has worked in the health, education and social sectors for many years. Tuari is also the Chair of the NZ Drug Foundation and is currently serving on the Southern District Health Board.
Dr Vicki MacFarlane has been a GP for three decades. She has worked for CADS Auckland since 2010, where she is Lead Clinician of the Medical Detoxification Service providing clinical leadership to both the inpatient and community detoxification services.
This series promises to be an insightful, meaningful and at times challenging kōrero about AOD issues in Aotearoa. It is being hosted by Whare Tukutuku, an integrated approach to alcohol and other drug challenges being co-developed by Te Rau Ora and NZ Drug Foundation.
Can Te Tiriti mitigate alcohol and other drugs harm in Māori communities? Register now.
A new report shows New Zealand’s failure to adequately diagnose and treat ADHD is likely leading to significant drug harm, including from alcohol and nicotine.
Our latest report pulls together international evidence and local experiences of how neurodivergence impacts drug use
‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.